Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 3721 AL 3735

Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson's disease

Hattori N, Takeda A, Takeda S, Nishimura A, Kitagawa T, Mochizuki H, Nagai M, Takahashi R.

J Neural Transm (Vienna). 2019 Mar;126(3):299-308. doi: 10.1007/s00702-018-1964-3. Epub 2019 Jan 28.

Compound heterozygous mutations in PARK2 causing early-onset Parkinson disease: A case report

Fang YQ, Mao F, Zhu MJ, Li XH.

Medicine (Baltimore). 2019 Feb;98(5):e14228. doi: 10.1097/MD.0000000000014228.

Essential Tremor

Reich SG.

Med Clin North Am. 2019 Mar;103(2):351-356. doi: 10.1016/j.mcna.2018.10.016.

Management of Pulse Generators in a Breast Cancer Patient with in Situ Subthalamic Nucleus Deep Brain Stimulation

Son BC, Kim JS, Park WC, Ko HC.

J Neurol Surg A Cent Eur Neurosurg. 2019 May;80(3):223-227. doi: 10.1055/s-0038-1677518. Epub 2019 Feb 1.

EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease

Dafsari HS, Martinez-Martin P, Rizos A, Trost M, Dos Santos Ghilardi MG, Reddy P, Sauerbier A, Petry-Schmelzer JN, Kramberger M, Borgemeester RWK, Barbe MT, Ashkan K, Silverdale M, Evans J, Odin P, Fonoff ET, Fink GR, Henriksen T, Ebersbach G, Pirtošek Z, Visser-Vandewalle V, Antonini A, Timmermann L, Ray Chaudhuri K; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group.

Mov Disord. 2019 Mar;34(3):353-365. doi: 10.1002/mds.27626. Epub 2019 Feb 4.

Emerging links between pediatric lysosomal storage diseases and adult parkinsonism

Ysselstein D, Shulman JM, Krainc D.

Mov Disord. 2019 May;34(5):614-624. doi: 10.1002/mds.27631. Epub 2019 Feb 6.

Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson's disease

Zhou ZD, Selvaratnam T, Lee JCT, Chao YX, Tan EK.

Transl Neurodegener. 2019 Feb 4;8:6. doi: 10.1186/s40035-019-0145-0. eCollection 2019.

Trehalose as a promising therapeutic candidate for the treatment of Parkinson's disease

Khalifeh M, Barreto GE, Sahebkar A.

Br J Pharmacol. 2019 May;176(9):1173-1189. doi: 10.1111/bph.14623. Epub 2019 Mar 27.

A Review on the Relationship Between Sound and Movement in Sports and Rehabilitation

Schaffert N, Janzen TB, Mattes K, Thaut MH.

Front Psychol. 2019 Feb 12;10:244. doi: 10.3389/fpsyg.2019.00244. eCollection 2019.

Virtual reality during gait training: does it improve gait function in persons with central nervous system movement disorders? A systematic review and meta-analysis

De Keersmaecker E, Lefeber N, Geys M, Jespers E, Kerckhofs E, Swinnen E.

NeuroRehabilitation. 2019;44(1):43-66. doi: 10.3233/NRE-182551.

Resting-state Functional MRI in Parkinsonian Syndromes

Filippi M, Sarasso E, Agosta F.

Mov Disord Clin Pract. 2019 Feb 8;6(2):104-117. doi: 10.1002/mdc3.12730. eCollection 2019 Feb.

Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease

Kang UJ, Boehme AK, Fairfoul G, Shahnawaz M, Ma TC, Hutten SJ, Green A, Soto C.

Mov Disord. 2019 Apr;34(4):536-544. doi: 10.1002/mds.27646. Epub 2019 Mar 6.

Rare histotype of sporadic Creutzfeldt-Jakob disease, clinically suspected as corticobasal degeneration

Tilley BS, Smith C, Pavese N, Attems J.

BMJ Case Rep. 2019 Mar 7;12(3):e228305. doi: 10.1136/bcr-2018-228305.

Cellular, molecular, and clinical mechanisms of action of deep brain stimulation-a systematic review on established indications and outlook on future developments

Jakobs M, Fomenko A, Lozano AM, Kiening KL.

EMBO Mol Med. 2019 Apr;11(4):e9575. doi: 10.15252/emmm.201809575.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias